More than half of the National Institutes of Health's 27 institutes and centers are missing permanent directors, giving the ...

"He kept reassuring me. He said, 'No, he's gonna be fine. He's gonna smile again,'" she shares. "After six days in the ICU, my husband got him to smile at him. Every single day, he started getting ...

Imran Khan's vision loss has necessitated a move from prison to a specialised hospital for urgent ophthalmic care ...

In the recreation room at Eskaton Village in Carmichael, Bonnie Dale, one of the residents, is trying on a virtual reality ...

February is Low Vision Awareness Month, a time to recognize the millions of people living with reduced vision.

Humans develop sharp vision during early fetal development thanks to an interplay between a vitamin A derivative and thyroid hormones in the retina, Johns Hopkins University scientists have found. The ...

As a robot stared into my eyes, I was perhaps getting a look at the future along with a prescription for eyeglasses. A robot ...

PDE6A-associated RP, a rare form of inherited retinal disease (IRD), is characterized by nyctalopia, visual field defects, and significant loss of visual acuity (VA). The disease primarily affects the ...

Discover how tiny, cutting‑edge surgical tools are transforming glaucoma care with a gentler, less invasive approach. Learn why Moran Eye Center experts use MIGS to help protect vision earlier and ...

Trachoma, an infectious eye disease and once a leading cause of blindness, is declining worldwide. Explore how it spreads, its long history, and how global efforts are working to end it.

Piper Sandler & Co. is serving as the sole manager for the Offering. The Offering is expected to close on or about February 17, 2026, subject to the satisfaction of customary closing conditions.

OKYO Pharma Limited (Nasdaq: OKYO), a clinical-stage biopharmaceutical company developing investigational therapies for the ...